DiaMedica Therapeutics Inc. - Common Stock (NQ:DMAC)

8.230 -0.120 (-1.44%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DiaMedica Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results

November 13, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023

November 09, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023

November 06, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

Earnings Preview: DiaMedica Therapeutics ↗

May 12, 2023

Via Benzinga

DiaMedica Therapeutics's Earnings Outlook ↗

March 27, 2023

Via Benzinga

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Earnings Outlook For DiaMedica Therapeutics ↗

November 10, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 25, 2023

Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.

Via InvestorPlace

DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer

September 12, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference

September 06, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results

August 14, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023

August 08, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference

July 18, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

Three (3) Stocks Under $10 That Insiders Are Buying

July 05, 2023

These small-cap names provide an opportunity that insiders are buying including deep value, growth, new technology, and AI.

Via MarketBeat

Topics Artificial Intelligence

DiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement

June 26, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023 ↗

June 22, 2023

Via Benzinga

DiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199 ↗

June 21, 2023

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has entered into an agreement with accredited investors that have agreed to provide up to $37.5 million in gross proceeds through a

Via Benzinga

DiaMedica Therapeutics Announces $37.5 Million Private Placement

June 21, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Stroke

June 21, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces Appointment of Dr. Richard Kuntz to the Board of Directors

May 30, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results

May 15, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

May 08, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer

April 11, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results

March 28, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023

March 20, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

March 13, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

March 06, 2023

From DiaMedica Therapeutics Inc.

Via Business Wire

$1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying ↗

December 02, 2022

The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results

November 09, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022

November 07, 2022

From DiaMedica Therapeutics Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.